Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes-Reference-Cited by-同舟云学术

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes

Published:2007-10 Issue:10 Volume:29 Page:2246-2255
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Orzeck Eric A.,Shi Nianwen,Blumentals William A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. Influenza associated hospitalizations in the United States;Thompson;JAMA,2004

2. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

3. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2006;55:800];Smith;MMWR Recomm Rep,2006

4. Observations on excess mortality associated with epidemic influenza;Eickhoff;JAMA,1961

5. Excess mortality from epidemic influenza, 1957-1966;Housworth;Am J Epidemiol,1974

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMMI Canada 2023 update on influenza: Management and emerging issues;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2023-11-29

2. Treatment and prevention of influenza in geriatric patients;Expert Review of Clinical Pharmacology;2023-08-07

3. Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes;The American Journal of Managed Care;2023-02-21

4. Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016‐2019;ACR Open Rheumatology;2022-05-12

5. Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia;Annals of Translational Medicine;2021-01